Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Jan;155(1):69-78.
doi: 10.1016/j.chest.2018.10.044.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD

Sunita Mulpuru  1 , Li Li  2 , Lingyun Ye  2 , Todd Hatchette  2 , Melissa K Andrew  2 , Ardith Ambrose  2 , Guy Boivin  3 , William Bowie  4 , Ayman Chit  5 , Gael Dos Santos  6 , May ElSherif  2 , Karen Green  7 , Francois Haguinet  8 , Scott A Halperin  2 , Barbara Ibarguchi  9 , Jennie Johnstone  10 , Kevin Katz  11 , Joanne M Langley  2 , Jason LeBlanc  2 , Mark Loeb  12 , Donna MacKinnon-Cameron  2 , Anne McCarthy  13 , Janet E McElhaney  14 , Allison McGeer  7 , Jeff Powis  15 , David Richardson  16 , Makeda Semret  17 , Vivek Shinde  18 , Daniel Smyth  19 , Sylvie Trottier  3 , Louis Valiquette  20 , Duncan Webster  21 , Shelly A McNeil  2 ; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Collaborators, Affiliations
Multicenter Study

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD

Sunita Mulpuru et al. Chest. 2019 Jan.

Abstract

Background: The effectiveness of influenza vaccination in reducing influenza-related hospitalizations among patients with COPD is not well described, and influenza vaccination uptake remains suboptimal.

Methods: Data were analyzed from a national, prospective, multicenter cohort study including patients with COPD, hospitalized with any acute respiratory illness or exacerbation between 2011 and 2015. All patients underwent nasopharyngeal swab screening with polymerase chain reaction (PCR) testing for influenza. The primary outcome was an influenza-related hospitalization. We identified influenza-positive cases and negative control subjects and used multivariable logistic regression with a standard test-negative design to estimate the vaccine effectiveness for preventing influenza-related hospitalizations.

Results: Among 4,755 hospitalized patients with COPD, 4,198 (88.3%) patients with known vaccination status were analyzed. The adjusted analysis showed a 38% reduction in influenza-related hospitalizations in vaccinated vs unvaccinated individuals. Influenza-positive patients (n = 1,833 [38.5%]) experienced higher crude mortality (9.7% vs 7.9%; P = .047) and critical illness (17.2% vs 12.1%; P < .001) compared with influenza-negative patients. Risk factors for mortality in influenza-positive patients included age > 75 years (OR, 3.7 [95% CI, 0.4-30.3]), cardiac comorbidity (OR, 2.0 [95% CI, 1.3-3.2]), residence in long-term care (OR, 2.6 [95% CI, 1.5-4.5]), and home oxygen use (OR, 2.9 [95% CI, 1.6-5.1]).

Conclusions: Influenza vaccination significantly reduced influenza-related hospitalization among patients with COPD. Initiatives to increase vaccination uptake and early use of antiviral agents among patients with COPD could reduce influenza-related hospitalization and critical illness and improve health-care costs in this vulnerable population.

Trial registry: ClinicalTrials.govNo.:NCT01517191; URL www.clinicaltrials.gov.

Keywords: COPD; hospitalization; influenza; pulmonary; vaccine effectiveness.

PubMed Disclaimer

Publication types

MeSH terms

Substances

Associated data

Grants and funding